Pathway Maps
KEGG PATHWAY is a collection of manually drawn pathway maps representing our knowledge of the molecular interaction, reaction and relation networks for:
The pathway map viewer linked from this page is a part of KEGG Web Apps and contains features of KEGG mapping.
1. Metabolism
Global/overview
Carbohydrate
Energy
Lipid
Nucleotide
Amino acid
Other amino
Glycan
Cofactor/vitamin
Terpenoid/PK
Other secondary metabolite
Xenobiotics
Chemical structure
2. Genetic Information Processing
3. Environmental Information Processing
4. Cellular Processes
5. Organismal Systems
6. Human Diseases
7. Drug Development
Pathway Identifiers
Each pathway map is identified by the combination of 2-4 letter prefix code and 5 digit number (see KEGG Identifier). The prefix has the following meaning:
Pathway maps are associated with KEGG modules, reaction modules, KEGG networks and taxonomy mapping.
- map
- manually drawn reference pathway
- ko
- reference pathway highlighting KOs
- ec
- reference metabolic pathway highlighting EC numbers
- rn
- reference metabolic pathway highlighting reactions
- <org>
- organism-specific pathway generated by converting KOs to gene identifiers
- 011
- global map (lines linked to KOs)
- 012
- overview map (lines linked to KOs)
- 013
- higher (multi-organism) level overview map (lines linked to KOs) New!
- 010
- chemical structure map (no KO expansion)
- 07
- drug structure map (no KO expansion)
- other
- regular map (boxes linked to KOs)
Pathway maps are associated with KEGG modules, reaction modules, KEGG networks and taxonomy mapping.
M - module
R - reaction module
N - network
T - taxonomy mapping New!
R - reaction module
N - network
T - taxonomy mapping New!
1. Metabolism
1.0 Global and overview maps- 01100 M
- Metabolic pathways
- 01110 M
- Biosynthesis of secondary metabolites
- 01120 M
- Microbial metabolism in diverse environments
- 01200 M R
- Carbon metabolism
- 01210 M R
- 2-Oxocarboxylic acid metabolism
- 01212 M R
- Fatty acid metabolism
- 01230 M R
- Biosynthesis of amino acids
- 01232 M R
- Nucleotide metabolism
- 01250 M R
- Biosynthesis of nucleotide sugars
- 01240 M R
- Biosynthesis of cofactors
- 01220 M R
- Degradation of aromatic compounds
- 01310 M T
- Nitrogen cycle New!
- 00010 M N
- Glycolysis / Gluconeogenesis
- 00020 M N
- Citrate cycle (TCA cycle)
- 00030 M
- Pentose phosphate pathway
- 00040 M
- Pentose and glucuronate interconversions
- 00051 M
- Fructose and mannose metabolism
- 00052 M N
- Galactose metabolism
- 00053 M
- Ascorbate and aldarate metabolism
- 00500 M N
- Starch and sucrose metabolism
- 00520 M N
- Amino sugar and nucleotide sugar metabolism
- 00620 M N
- Pyruvate metabolism
- 00630 M
- Glyoxylate and dicarboxylate metabolism
- 00640 M
- Propanoate metabolism
- 00650 M
- Butanoate metabolism
- 00660 M
- C5-Branched dibasic acid metabolism
- 00562 M
- Inositol phosphate metabolism
- 00190 M
- Oxidative phosphorylation
- 00195 M
- Photosynthesis
- 00196
- Photosynthesis - antenna proteins
- 00710 M
- Carbon fixation by Calvin cycle
- 00720 M
- Other carbon fixation pathways
- 00680 M
- Methane metabolism
- 00910 M
- Nitrogen metabolism
- 00920 M
- Sulfur metabolism
- 00061 M
- Fatty acid biosynthesis
- 00062 M
- Fatty acid elongation
- 00071 M N
- Fatty acid degradation
- 00073
- Cutin, suberine and wax biosynthesis
- 00074 M
- Mycolic acid biosynthesis New!
- 00100 M N
- Steroid biosynthesis
- 00120 M N
- Primary bile acid biosynthesis
- 00121
- Secondary bile acid biosynthesis
- 00140 M N
- Steroid hormone biosynthesis
- 00561 M
- Glycerolipid metabolism
- 00564 M
- Glycerophospholipid metabolism
- 00565 M
- Ether lipid metabolism
- 00600 M N
- Sphingolipid metabolism
- 00590
- Arachidonic acid metabolism
- 00591
- Linoleic acid metabolism
- 00592 M
- alpha-Linolenic acid metabolism
- 01040 M N
- Biosynthesis of unsaturated fatty acids
- 00230 M N
- Purine metabolism
- 00240 M
- Pyrimidine metabolism
- 00250 M
- Alanine, aspartate and glutamate metabolism
- 00260 M N
- Glycine, serine and threonine metabolism
- 00270 M N
- Cysteine and methionine metabolism
- 00280 M N
- Valine, leucine and isoleucine degradation
- 00290 M
- Valine, leucine and isoleucine biosynthesis
- 00300 M T
- Lysine biosynthesis
- 00310 M N
- Lysine degradation
- 00220 M N
- Arginine biosynthesis
- 00330 M N
- Arginine and proline metabolism
- 00340 M N
- Histidine metabolism
- 00350 M N
- Tyrosine metabolism
- 00360 M
- Phenylalanine metabolism
- 00380 M N
- Tryptophan metabolism
- 00400 M N
- Phenylalanine, tyrosine and tryptophan biosynthesis
- 00410 M
- beta-Alanine metabolism
- 00430 M
- Taurine and hypotaurine metabolism
- 00440
- Phosphonate and phosphinate metabolism
- 00450
- Selenocompound metabolism
- 00460 M
- Cyanoamino acid metabolism
- 00470 M
- D-Amino acid metabolism
- 00480 M N
- Glutathione metabolism
- 00510 M N
- N-Glycan biosynthesis
- 00513 M
- Various types of N-glycan biosynthesis
- 00512 M
- Mucin type O-glycan biosynthesis
- 00515 M N
- Mannose type O-glycan biosynthesis
- 00514
- Other types of O-glycan biosynthesis
- 00532 M N
- Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate
- 00534 M N
- Glycosaminoglycan biosynthesis - heparan sulfate / heparin
- 00533
- Glycosaminoglycan biosynthesis - keratan sulfate
- 00531 M N
- Glycosaminoglycan degradation
- 00563 M N
- Glycosylphosphatidylinositol (GPI)-anchor biosynthesis
- 00601 M N
- Glycosphingolipid biosynthesis - lacto and neolacto series
- 00603 M N
- Glycosphingolipid biosynthesis - globo and isoglobo series
- 00604 M
- Glycosphingolipid biosynthesis - ganglio series
- 00511
- Other glycan degradation
- 00540 M
- Lipopolysaccharide biosynthesis
- 00542
- O-Antigen repeat unit biosynthesis
- 00541 M
- O-Antigen nucleotide sugar biosynthesis
- 00550
- Peptidoglycan biosynthesis
- 00552
- Teichoic acid biosynthesis
- 00571
- Lipoarabinomannan (LAM) biosynthesis
- 00572 M
- Arabinogalactan biosynthesis - Mycobacterium
- 00543
- Exopolysaccharide biosynthesis
- 00730 M
- Thiamine metabolism
- 00740 M
- Riboflavin metabolism
- 00750 M
- Vitamin B6 metabolism
- 00760 M N
- Nicotinate and nicotinamide metabolism
- 00770 M
- Pantothenate and CoA biosynthesis
- 00780 M
- Biotin metabolism
- 00785 M N
- Lipoic acid metabolism
- 00790 M N
- Folate biosynthesis
- 00670 M N
- One carbon pool by folate
- 00830
- Retinol metabolism
- 00860 M N
- Porphyrin metabolism
- 00130 M
- Ubiquinone and other terpenoid-quinone biosynthesis
- 00900 M N
- Terpenoid backbone biosynthesis
- 00902
- Monoterpenoid biosynthesis
- 00909
- Sesquiterpenoid and triterpenoid biosynthesis
- 00904 M
- Diterpenoid biosynthesis
Including: Gibberellin biosynthesis - 00906 M
- Carotenoid biosynthesis
- 00905 M
- Brassinosteroid biosynthesis
- 00981
- Insect hormone biosynthesis
- 00908
- Zeatin biosynthesis
- 00903
- Limonene degradation
- 00907
- Pinene, camphor and geraniol degradation
- 01052
- Type I polyketide structures
- 00522 M
- Biosynthesis of 12-, 14- and 16-membered macrolides
Including: Tylosin biosynthesis, Mycinamicin biosynthesis, Erythromycin biosynthesis, Oleandomycin biosynthesis, Pikromycin/methymycin biosynthesis, Avermectin biosynthesis - 01051
- Biosynthesis of ansamycins
- 01059 M T
- Biosynthesis of enediyne antibiotics
- 01056 M
- Biosynthesis of type II polyketide backbone
- 01057 M T
- Biosynthesis of type II polyketide products
- 00253 M
- Tetracycline biosynthesis
- 00523 M T
- Polyketide sugar unit biosynthesis
- 01054
- Nonribosomal peptide structures
- 01053
- Biosynthesis of siderophore group nonribosomal peptides
- 01055
- Biosynthesis of vancomycin group antibiotics
- 00940 M
- Phenylpropanoid biosynthesis
- 00945
- Stilbenoid, diarylheptanoid and gingerol biosynthesis
- 00941 M
- Flavonoid biosynthesis
- 00944
- Flavone and flavonol biosynthesis
- 00942
- Anthocyanin biosynthesis
- 00943 M
- Isoflavonoid biosynthesis
- 00946 M T
- Degradation of flavonoids
- 00901 M T
- Indole alkaloid biosynthesis
- 00403 M
- Indole diterpene alkaloid biosynthesis
- 00950 M
- Isoquinoline alkaloid biosynthesis
- 00960
- Tropane, piperidine and pyridine alkaloid biosynthesis
- 00996
- Biosynthesis of various alkaloids
Including: Cucurbitacin biosynthesis, Solanine and tomatine biosynthesis, Ephedrine biosynthesis, Capsaicin biosynthesis, Acridone alkaloid biosynthesis - 00232 M
- Caffeine metabolism
- 00965 M
- Betalain biosynthesis
- 00966 M
- Glucosinolate biosynthesis
- 00402
- Benzoxazinoid biosynthesis
- 00311 M T
- Penicillin and cephalosporin biosynthesis
- 00332 M
- Carbapenem biosynthesis
- 00261 M
- Monobactam biosynthesis
- 00331 M
- Clavulanic acid biosynthesis
- 00521 M
- Streptomycin biosynthesis
- 00524
- Neomycin, kanamycin and gentamicin biosynthesis
- 00525 M T
- Acarbose and validamycin biosynthesis
- 00401
- Novobiocin biosynthesis
- 00404 M T
- Staurosporine biosynthesis
- 00405 M
- Phenazine biosynthesis
- 00333 M T
- Prodigiosin biosynthesis
- 00254 M
- Aflatoxin biosynthesis
- 00998 M T
- Biosynthesis of various antibiotics
Including: Kanosamine biosynthesis, Aurachin biosynthesis, Bacilysin biosynthesis, Puromycin biosynthesis, Dapdiamides biosynthesis, Fosfomycin biosynthesis, Cremeomycin biosynthesis, Fumagillin biosynthesis, Pentalenolactone biosynthesis, Terpentecin biosynthesis, Roseoflavin biosynthesis, Cycloserine biosynthesis - 00999 M T
- Biosynthesis of various plant secondary metabolites
Including: Crocin biosynthesis, Ginsenoside biosynthesis, Saponin adjuvant biosynthesis, Cannabidiol biosynthesis, Mugineic acid biosynthesis, Pentagalloylglucose biosynthesis, Benzoxazinoid biosynthesis, Gramine biosynthesis, Coumarin biosynthesis, Furanocoumarin biosynthesis, Hordatine biosynthesis, Podophyllotoxin biosynthesis - 00997 M T
- Biosynthesis of various other secondary metabolites
Including: Ditryptophenaline biosynthesis, Fumiquinazoline D biosynthesis, Paerucumarin biosynthesis, Staphyloferrin B biosynthesis, Cyclooctatin biosynthesis, Lovastatin biosynthesis, Grixazone biosynthesis, Staphyloferrin A biosynthesis, Ethynylserine biosynthesis, Aerobactin biosynthesis
- 00362 M T
- Benzoate degradation
- 00627 M
- Aminobenzoate degradation
- 00364
- Fluorobenzoate degradation
- 00625
- Chloroalkane and chloroalkene degradation
- 00361 M
- Chlorocyclohexane and chlorobenzene degradation
- 00623 M T
- Toluene degradation
- 00622 M
- Xylene degradation
- 00633
- Nitrotoluene degradation
- 00642
- Ethylbenzene degradation
- 00643
- Styrene degradation
- 00791
- Atrazine degradation
- 00930
- Caprolactam degradation
- 00363
- Bisphenol degradation
- 00621 M T
- Dioxin degradation
- 00626 M
- Naphthalene degradation
- 00624 M T
- Polycyclic aromatic hydrocarbon degradation
- 00365
- Furfural degradation
- 00984
- Steroid degradation
- 00980
- Metabolism of xenobiotics by cytochrome P450
- 00982
- Drug metabolism - cytochrome P450
- 00983
- Drug metabolism - other enzymes
- 01010
- Overview of biosynthetic pathways
- 01060
- Biosynthesis of plant secondary metabolites
- 01061
- Biosynthesis of phenylpropanoids
- 01062
- Biosynthesis of terpenoids and steroids
- 01063
- Biosynthesis of alkaloids derived from shikimate pathway
- 01064
- Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid
- 01065
- Biosynthesis of alkaloids derived from histidine and purine
- 01066
- Biosynthesis of alkaloids derived from terpenoid and polyketide
- 01070
- Biosynthesis of plant hormones
2. Genetic Information Processing
2.1 Transcription- 03020
- RNA polymerase
- 03022
- Basal transcription factors
- 03040
- Spliceosome
- 03060
- Protein export
- 04141 N
- Protein processing in endoplasmic reticulum
- 04130
- SNARE interactions in vesicular transport
- 04120
- Ubiquitin mediated proteolysis
- 04122
- Sulfur relay system
- 03050
- Proteasome
- 03018
- RNA degradation
- 03030
- DNA replication
- 03410 N
- Base excision repair
- 03420 N
- Nucleotide excision repair
- 03430
- Mismatch repair
- 03440
- Homologous recombination
- 03450
- Non-homologous end-joining
- 03460
- Fanconi anemia pathway
- 03230
- Viral genome structure
- 03240
- Viral replication
- 03250
- Viral life cycle - HIV-1
- 03260
- Virion - Human immunodeficiency virus
- 03271
- Virion - Rotavirus
- 03262
- Virion - Coronavirus
- 03261
- Virion - Influenza virus
- 03263
- Virion - Enterovirus
- 03264
- Virion - Flavivirus and Alphavirus
- 03265
- Virion - Ebolavirus, Lyssavirus and Morbillivirus
- 03273
- Virion - Lassa virus and SFTS virus New!
- 03272
- Virion - Hepatitis viruses New!
- 03266
- Virion - Herpesvirus
- 03268
- Virion - Orthopoxvirus
- 03267
- Virion - Adenovirus
- 03259
- Virion - Bacteriophages T4 and T7
- 03258
- Virion - Bacteriophage lambda
3. Environmental Information Processing
3.1 Membrane transport 3.2 Signal transduction- 02020
- Two-component system
- 04010 N
- MAPK signaling pathway
- 04013
- MAPK signaling pathway - fly
- 04016
- MAPK signaling pathway - plant
- 04011
- MAPK signaling pathway - yeast
- 04012 N
- ErbB signaling pathway
- 04014 N
- Ras signaling pathway
- 04015
- Rap1 signaling pathway
- 04310 N
- Wnt signaling pathway
- 04330 N
- Notch signaling pathway
- 04340 N
- Hedgehog signaling pathway
- 04341
- Hedgehog signaling pathway - fly
- 04350 N
- TGF-beta signaling pathway
- 04390
- Hippo signaling pathway
- 04391
- Hippo signaling pathway - fly
- 04392
- Hippo signaling pathway - multiple species
- 04370
- VEGF signaling pathway
- 04371
- Apelin signaling pathway
- 04630 N
- JAK-STAT signaling pathway
- 04064 N
- NF-kappa B signaling pathway
- 04668 N
- TNF signaling pathway
- 04066 N
- HIF-1 signaling pathway
- 04068
- FoxO signaling pathway
- 04020 N
- Calcium signaling pathway
- 04070
- Phosphatidylinositol signaling system
- 04072
- Phospholipase D signaling pathway
- 04071
- Sphingolipid signaling pathway
- 04024 N
- cAMP signaling pathway
- 04022
- cGMP-PKG signaling pathway
- 04151 N
- PI3K-Akt signaling pathway
- 04152
- AMPK signaling pathway
- 04150 N
- mTOR signaling pathway
- 04075
- Plant hormone signal transduction
4. Cellular Processes
4.1 Transport and catabolism- 04144
- Endocytosis
- 04145 N
- Phagosome
- 04142
- Lysosome
- 04146
- Peroxisome
- 04140 N
- Autophagy - animal
- 04138
- Autophagy - yeast
- 04136
- Autophagy - other
- 04137 N
- Mitophagy - animal
- 04139
- Mitophagy - yeast
- 04148 N
- Efferocytosis
- 04110 N
- Cell cycle
- 04111
- Cell cycle - yeast
- 04112
- Cell cycle - Caulobacter
- 04113
- Meiosis - yeast
- 04114
- Oocyte meiosis
- 04210 N
- Apoptosis
- 04214
- Apoptosis - fly
- 04215
- Apoptosis - multiple species
- 04216 N
- Ferroptosis
- 04217 N
- Necroptosis
- 04115
- p53 signaling pathway
- 04218
- Cellular senescence
- 04510 N
- Focal adhesion
- 04520
- Adherens junction
- 04530 N
- Tight junction
- 04540
- Gap junction
- 04550
- Signaling pathways regulating pluripotency of stem cells
- 02030
- Bacterial chemotaxis
- 02040
- Flagellar assembly
- 04814
- Motor proteins
- 04820 N
- Cytoskeleton in muscle cells
- 04810
- Regulation of actin cytoskeleton
5. Organismal Systems
5.1 Immune system- 04640
- Hematopoietic cell lineage
- 04610 N
- Complement and coagulation cascades
- 04611
- Platelet activation
- 04613
- Neutrophil extracellular trap formation
- 04620 N
- Toll-like receptor signaling pathway
- 04624
- Toll and Imd signaling pathway
- 04621 N
- NOD-like receptor signaling pathway
- 04622 N
- RIG-I-like receptor signaling pathway
- 04623 N
- Cytosolic DNA-sensing pathway
- 04625
- C-type lectin receptor signaling pathway
- 04650
- Natural killer cell mediated cytotoxicity
- 04612 N
- Antigen processing and presentation
- 04660 N
- T cell receptor signaling pathway
- 04658
- Th1 and Th2 cell differentiation
- 04659
- Th17 cell differentiation
- 04657
- IL-17 signaling pathway
- 04662 N
- B cell receptor signaling pathway
- 04664
- Fc epsilon RI signaling pathway
- 04666 N
- Fc gamma R-mediated phagocytosis
- 04670
- Leukocyte transendothelial migration
- 04672
- Intestinal immune network for IgA production
- 04062 N
- Chemokine signaling pathway
- 04911
- Insulin secretion
- 04910
- Insulin signaling pathway
- 04922
- Glucagon signaling pathway
- 04923
- Regulation of lipolysis in adipocytes
- 04920 N
- Adipocytokine signaling pathway
- 03320
- PPAR signaling pathway
- 04929 N
- GnRH secretion
- 04912 N
- GnRH signaling pathway
- 04913
- Ovarian steroidogenesis
- 04915 N
- Estrogen signaling pathway
- 04914
- Progesterone-mediated oocyte maturation
- 04917 N
- Prolactin signaling pathway
- 04921
- Oxytocin signaling pathway
- 04926
- Relaxin signaling pathway
- 04935 N
- Growth hormone synthesis, secretion and action
- 04918 N
- Thyroid hormone synthesis
- 04919 N
- Thyroid hormone signaling pathway
- 04928 N
- Parathyroid hormone synthesis, secretion and action
- 04916
- Melanogenesis
- 04924 N
- Renin secretion
- 04614 N
- Renin-angiotensin system
- 04925 N
- Aldosterone synthesis and secretion
- 04927 N
- Cortisol synthesis and secretion
- 04970
- Salivary secretion
- 04971
- Gastric acid secretion
- 04972
- Pancreatic secretion
- 04976
- Bile secretion
- 04973
- Carbohydrate digestion and absorption
- 04974
- Protein digestion and absorption
- 04975
- Fat digestion and absorption
- 04979 N
- Cholesterol metabolism
- 04977 N
- Vitamin digestion and absorption
- 04981
- Folate transport and metabolism New!
- 04980 N
- Cobalamin transport and metabolism
- 04978
- Mineral absorption
- 04724 N
- Glutamatergic synapse
- 04727
- GABAergic synapse
- 04725
- Cholinergic synapse
- 04728 N
- Dopaminergic synapse
- 04726
- Serotonergic synapse
- 04720 N
- Long-term potentiation
- 04730 N
- Long-term depression
- 04723
- Retrograde endocannabinoid signaling
- 04721
- Synaptic vesicle cycle
- 04722
- Neurotrophin signaling pathway
- 04320
- Dorso-ventral axis formation
- 04360
- Axon guidance
- 04361
- Axon regeneration
- 04380
- Osteoclast differentiation
- 04710
- Circadian rhythm
- 04713
- Circadian entrainment
- 04711
- Circadian rhythm - fly
- 04712
- Circadian rhythm - plant
- 04714 N
- Thermogenesis
- 04626
- Plant-pathogen interaction
6. Human Diseases
6.1 Cancer: overview- 05200 N
- Pathways in cancer
- 05202
- Transcriptional misregulation in cancer
- 05206
- MicroRNAs in cancer
- 05205
- Proteoglycans in cancer
- 05204 N
- Chemical carcinogenesis - DNA adducts
- 05207 N
- Chemical carcinogenesis - receptor activation
- 05208 N
- Chemical carcinogenesis - reactive oxygen species
- 05203
- Viral carcinogenesis
- 05230
- Central carbon metabolism in cancer
- 05231
- Choline metabolism in cancer
- 05235
- PD-L1 expression and PD-1 checkpoint pathway in cancer
- 05210 N
- Colorectal cancer
- 05212 N
- Pancreatic cancer
- 05225 N
- Hepatocellular carcinoma
- 05226 N
- Gastric cancer
- 05214 N
- Glioma
- 05216 N
- Thyroid cancer
- 05221 N
- Acute myeloid leukemia
- 05220 N
- Chronic myeloid leukemia
- 05217 N
- Basal cell carcinoma
- 05218 N
- Melanoma
- 05211 N
- Renal cell carcinoma
- 05219 N
- Bladder cancer
- 05215 N
- Prostate cancer
- 05213 N
- Endometrial cancer
- 05224 N
- Breast cancer
- 05222 N
- Small cell lung cancer
- 05223 N
- Non-small cell lung cancer
- 05166 N
- Human T-cell leukemia virus 1 infection
- 05170 N
- Human immunodeficiency virus 1 infection
- 05161 N
- Hepatitis B
- 05160 N
- Hepatitis C
- 05171 N
- Coronavirus disease - COVID-19
- 05164 N
- Influenza A
- 05162 N
- Measles
- 05168 N
- Herpes simplex virus 1 infection
- 05163 N
- Human cytomegalovirus infection
- 05167 N
- Kaposi sarcoma-associated herpesvirus infection
- 05169 N
- Epstein-Barr virus infection
- 05165 N
- Human papillomavirus infection
- 05110
- Vibrio cholerae infection
- 05120
- Epithelial cell signaling in Helicobacter pylori infection
- 05130 N
- Pathogenic Escherichia coli infection
- 05132 N
- Salmonella infection
- 05131 N
- Shigellosis
- 05135 N
- Yersinia infection
- 05133
- Pertussis
- 05134
- Legionellosis
- 05150
- Staphylococcus aureus infection
- 05152
- Tuberculosis
- 05100
- Bacterial invasion of epithelial cells
- 05146
- Amoebiasis
- 05144
- Malaria
- 05145
- Toxoplasmosis
- 05140
- Leishmaniasis
- 05142
- Chagas disease
- 05143
- African trypanosomiasis
- 05310
- Asthma
- 05322
- Systemic lupus erythematosus
- 05323
- Rheumatoid arthritis
- 05320
- Autoimmune thyroid disease
- 05321
- Inflammatory bowel disease
- 05330
- Allograft rejection
- 05332
- Graft-versus-host disease
- 05340
- Primary immunodeficiency
- 05010 N
- Alzheimer disease
- 05012 N
- Parkinson disease
- 05014 N
- Amyotrophic lateral sclerosis
- 05016 N
- Huntington disease
- 05017 N
- Spinocerebellar ataxia
- 05020 N
- Prion disease
- 05022 N
- Pathways of neurodegeneration - multiple diseases
- 05030
- Cocaine addiction
- 05031
- Amphetamine addiction
- 05032
- Morphine addiction
- 05033
- Nicotine addiction
- 05034
- Alcoholism
7. Drug Development
7.1 Chronology: Antiinfectives- 07011
- Penicillins
- 07012
- Cephalosporins - parenteral agents
- 07013
- Cephalosporins - oral agents
- 07021
- Aminoglycosides
- 07019
- Tetracyclines
- 07020
- Macrolides and ketolides
- 07014
- Quinolones
- 07023
- Rifamycins
- 07026
- Antifungal agents
- 07044
- Antiviral agents
- 07053
- Anti-HIV agents
- 07032
- Hypnotics
- 07030
- Anxiolytics
- 07033
- Anticonvulsants
- 07015
- Local analgesics
- 07039
- Opioid analgesics
- 07028
- Antipsychotics
- 07029
- Antipsychotics - phenothiazines
- 07031
- Antipsychotics - butyrophenones
- 07027
- Antidepressants
- 07056
- Agents for Alzheimer-type dementia
- 07057
- Antiparkinsonian agents
- 07055
- Sulfonamide derivatives - overview
- 07016
- Sulfonamide derivatives - sulfa drugs
- 07017
- Sulfonamide derivatives - diuretics
- 07018
- Sulfonamide derivatives - hypoglycemic agents
- 07037
- Antiarrhythmic drugs
- 07038
- Antiulcer drugs
- 07046
- Immunosuppressive agents
- 07047
- Osteoporosis drugs
- 07048
- Antimigraines
- 07049
- Antithrombosis agents
- 07050
- Antirheumatics - DMARDs and biological agents
- 07051
- Antidiabetics
- 07052
- Antidyslipidemic agents
- 07054
- Antiglaucoma agents
- 07220
- Cholinergic and anticholinergic drugs
- 07215
- alpha-Adrenergic receptor agonists/antagonists
- 07214
- beta-Adrenergic receptor agonists/antagonists
- 07213
- Dopamine receptor agonists/antagonists
- 07212
- Histamine H1 receptor antagonists
- 07227
- Histamine H2/H3 receptor agonists/antagonists
- 07211
- Serotonin receptor agonists/antagonists
- 07228
- Eicosanoid receptor agonists/antagonists
- 07224
- Opioid receptor agonists/antagonists
- 07229
- Angiotensin receptor and endothelin receptor antagonists
- 07025
- Quinolines
- 07034
- Eicosanoids
- 07035
- Prostaglandins
- 07110
- Benzoic acid family
- 07112
- 1,2-Diphenyl substitution family
- 07114
- Naphthalene family
- 07117
- Benzodiazepine family
Last updated: December 2, 2024